Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 216

Results For "US"

8096 News Found

Lincoln Pharma gets Australian TGA approval
News | October 08, 2021

Lincoln Pharma gets Australian TGA approval

The company plans to expand its portfolio in regulated markets aggressively


PerkinElmer receives FDA Emergency Use Authorization for respiratory SARS-CoV-2 Panel
Medical Device | October 07, 2021

PerkinElmer receives FDA Emergency Use Authorization for respiratory SARS-CoV-2 Panel

RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus


Twin Health raises US $ 140 million in Series C funding
Startup | October 07, 2021

Twin Health raises US $ 140 million in Series C funding

The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service


Ayushman Bharat PM-JAY rates revised
Public Health | October 06, 2021

Ayushman Bharat PM-JAY rates revised

The rates for over 400 procedures were revised


Boston Scientific to acquire Baylis Medical Company for US $ 1.75 billion
Medical Device | October 06, 2021

Boston Scientific to acquire Baylis Medical Company for US $ 1.75 billion

The transaction is anticipated to close in the first quarter of 2022


Pradhan Mantri Bhartiya Janaushadhi Pariyojana stores open in all  districts
Public Health | October 06, 2021

Pradhan Mantri Bhartiya Janaushadhi Pariyojana stores open in all districts

A total of 8308 stores are open across India and medicines are priced at affordable rates


Zuellig Pharma receives EcoVadis Platinum medal for sustainability
Sustainability | October 05, 2021

Zuellig Pharma receives EcoVadis Platinum medal for sustainability

The company's sustainability programme was evaluated on its policies, actions put in place to support objectives and targets, as well as results that were generated from the programme


AstraZeneca requests Emergency Use Authorisation for drug to prevent Covid
Biotech | October 05, 2021

AstraZeneca requests Emergency Use Authorisation for drug to prevent Covid

The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)


Biocon launches Everolimus tablets in the US
Drug Approval | October 04, 2021

Biocon launches Everolimus tablets in the US

According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021


Natco announces launch of 10 mg Everolimus in the US
Drug Approval | October 01, 2021

Natco announces launch of 10 mg Everolimus in the US

According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021